🔎 Trials Near Me

Home › Diffuse Large B-Cell Lymphoma › Florida › Miami

Diffuse Large B-Cell Lymphoma clinical trials in Miami, FL

7 studies for Diffuse Large B-Cell Lymphoma are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

RecruitingPhase 1/2
  • Mount Sinai Medical Center Braman Comprehensive Cancer Center, Miami
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT05006716

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

RecruitingPhase 1
  • University of Miami - Sylvester Cancer Center, Miami
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07226843

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

RecruitingPhase 2
  • Mount Sinai Comprehensive Cancer Center, Miami
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06806033

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

RecruitingPhase 2
  • Miami Cancer Institute at Baptist Health, Inc., Miami
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT06500273

DALY II USA/ MB-CART2019.1 for DLBCL

RecruitingPhase 2
  • Baptist Health Miami Cancer Institute, Miami
Ages 18 and older · All sexes · Updated Jul 13, 2026 · NCT04792489

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

RecruitingPhase 1
  • University of Miami, Miami
Ages 18 and older · All sexes · Updated Jul 2, 2026 · NCT05131022

A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma

RecruitingPhase 2
  • University of Miami Sylvester Cancer Center, Miami
Ages 18 and older · All sexes · Updated Mar 5, 2026 · NCT05800366

Diffuse Large B-Cell Lymphoma trials in other cities

Other studies in Miami

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.